Compare EVMN & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVMN | NUS |
|---|---|---|
| Founded | 2020 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.6M | 469.0M |
| IPO Year | 2025 | 1996 |
| Metric | EVMN | NUS |
|---|---|---|
| Price | $28.46 | $10.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $44.17 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 499.5K |
| Earning Date | 06-10-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.20 |
| Revenue | $13,000,000.00 | ★ $1,560,391,000.00 |
| Revenue This Year | $89.43 | N/A |
| Revenue Next Year | N/A | $2.12 |
| P/E Ratio | ★ N/A | $4.52 |
| Revenue Growth | ★ 160.00 | N/A |
| 52 Week Low | $13.89 | $5.32 |
| 52 Week High | $33.20 | $14.62 |
| Indicator | EVMN | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 45.18 |
| Support Level | $15.97 | $9.86 |
| Resistance Level | $33.20 | $10.92 |
| Average True Range (ATR) | 3.05 | 0.44 |
| MACD | 0.89 | -0.09 |
| Stochastic Oscillator | 74.38 | 18.95 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.